Bill
A 3775
Bill A 3775 allows healthcare providers to prescribe psilocybin for mental health treatment, promoting research and establishing safety guidelines for its medical use.
Bill Number: A 3775
Title: Relates to medical use of psilocybin; appropriation
Status: Referred to Health
Introduced: January 30, 2025
Classification: Bill
Bill A 3775 aims to establish a framework for the medical use of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms. The bill seeks to facilitate research and therapeutic applications of psilocybin for patients suffering from various mental health conditions, including but not limited to depression, anxiety, and PTSD. The intent is to provide a regulated pathway for the medical community to explore the potential benefits of psilocybin in treating these conditions.
Medical Use Authorization: The bill proposes to allow licensed healthcare providers to prescribe psilocybin to patients under specific medical circumstances.
Research and Development: It encourages clinical trials and research initiatives to gather data on the efficacy and safety of psilocybin for therapeutic use.
Regulatory Framework: Establishes guidelines for the production, distribution, and administration of psilocybin, ensuring that it is used safely and effectively within a medical context.
Funding Appropriation: The bill includes provisions for the appropriation of funds to support research, training for healthcare providers, and public education regarding the medical use of psilocybin.
Patients: Individuals with mental health conditions who may benefit from psilocybin therapy.
Healthcare Providers: Physicians and mental health professionals who would be authorized to prescribe psilocybin and participate in research initiatives.
Research Institutions: Organizations conducting studies on psilocybin's therapeutic effects would receive funding and support.
Regulatory Bodies: State health departments and other regulatory agencies would be tasked with overseeing the implementation of the bill's provisions.
Current Status: As of January 30, 2025, the bill has been referred to the Health Committee for further consideration.
Related Legislation: This bill is related to prior-session bills A 8569 and A 3581, as well as Senate Bill S 495, which serves as its companion. These related bills may provide context or additional frameworks for the medical use of psilocybin.
Bill A 3775 represents a significant step towards integrating psilocybin into medical practice, potentially offering new treatment options for patients with mental health challenges. As it moves through the legislative process, further discussions and amendments may shape its final form and implementation.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
